Back to Search
RYAN MCKELVIE, PHARMD
PHARMD
Pharmacist
NPI: 1487536603Individual
Specialties, Licenses & Credentials
PharmacistPrimary
Pharmacist
Code: 183500000X
061849(NY)
Research & Publications (20)
The CHARM program: the effects of candesartan for the management of patients with chronic heart failure.
PMID 19105762·Expert Rev Cardiovasc Ther·2009
6-review
Efficacy and safety of exercise training in patients with chronic heart failure: HF-ACTION randomized controlled trial.
PMID 19351941·JAMA·2009
4-observational
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure, update 2009: diagnosis and management of right-sided heart failure, myocarditis, device therapy and recent important clinical trials.
PMID 19214293·Can J Cardiol·2009
6-review
Effects of enalapril, candesartan or both on neurohumoral activation and LV volumes and function in patients with heart failure not treated with a beta-blocker.
PMID 19299427·Ther Adv Cardiovasc Dis·2009
4-observational
Puzzling practice: a strategy for working with clinical practice issues.
PMID 18315821·Int J Nurs Pract·2008
8-other
Irbesartan in patients with heart failure and preserved ejection fraction.
PMID 19001508·N Engl J Med·2008
4-observational
Cardiovascular aging and exercise in healthy older adults.
PMID 19001881·Clin J Sport Med·2008
6-review
Physiological, pathological, pharmacological, biochemical and hematological factors affecting BNP and NT-proBNP.
PMID 17967418·Clin Biochem·2008
8-other
Diabetes, left ventricular systolic dysfunction, and chronic heart failure.
PMID 18424786·Eur Heart J·2008
6-review
BNP and NT-proBNP predict echocardiographic severity of diastolic dysfunction.
PMID 18331967·Eur J Heart Fail·2008
8-other
Exercise training in patients with heart failure: clinical outcomes, safety, and indications.
PMID 17960476·Heart Fail Rev·2008
6-review
Heart failure with preserved ejection fraction: clinical characteristics of 4133 patients enrolled in the I-PRESERVE trial.
PMID 18279770·Eur J Heart Fail·2008
2-rct
Relationships between plasma levels of matrix metalloproteinases and neurohormonal profile in patients with heart failure.
PMID 18234554·Eur J Heart Fail·2008
2-rct
Canadian Cardiovascular Society Consensus Conference guidelines on heart failure--2008 update: best practices for the transition of care of heart failure patients, and the recognition, investigation and treatment of cardiomyopathies.
PMID 18209766·Can J Cardiol·2008
6-review
Reproducibility of peak oxygen uptake and other cardiopulmonary exercise testing parameters in patients with heart failure (from the Heart Failure and A Controlled Trial Investigating Outcomes of exercise traiNing).
PMID 18773994·Am J Cardiol·2008
4-observational
Usefulness of N-terminal pro-brain natriuretic Peptide and brain natriuretic peptide to predict cardiovascular outcomes in patients with heart failure and preserved left ventricular ejection fraction.
PMID 18773998·Am J Cardiol·2008
4-observational
A systematic review of BNP as a predictor of prognosis in persons with coronary artery disease.
PMID 17949703·Clin Biochem·2008
1-meta
Monitoring the response to pharmacologic therapy in patients with stable chronic heart failure: is BNP or NT-proBNP a useful assessment tool?
PMID 17991434·Clin Biochem·2008
1-meta
Evidence for the use of B-type natriuretic peptides for screening asymptomatic populations and for diagnosis in primary care.
PMID 17920053·Clin Biochem·2008
1-meta
Diagnostic accuracy of BNP and NT-proBNP in patients presenting to acute care settings with dyspnea: a systematic review.
PMID 17915204·Clin Biochem·2008
1-meta
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1142 WEHRLE DR
WILLIAMSVILLE, NY 14221 - Phone
- (716) 631-3381
Quick Facts
- NPI
- 1487536603
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile